Drug Comparison

Compounded Semaglutide vs Brand-Name Semaglutide: What to Know Before You Choose (2026)

Compounded semaglutide became widely available during the 2022–2024 supply shortage and is still offered by some pharmacies. This page covers what compounding actually means, the current regulatory picture, and the questions worth asking before you consider it.

By GLP-1 Explained Editorial  ·  Updated September 2026  ·  9 min read  ·  Contains affiliate links

2022–2024
The period the FDA listed semaglutide injection as being in shortage, during which compounding by licensed pharmacies was permitted
503A / 503B
The two categories of pharmacy allowed to compound medications under U.S. law, with different rules and oversight
0
FDA-approved compounded versions of semaglutide — compounded products are not reviewed or verified for safety and effectiveness the way Ozempic and Wegovy are

During the 2022–2024 nationwide shortage of semaglutide injection, licensed compounding pharmacies were legally permitted to prepare and dispense versions of the drug to meet demand the brand-name manufacturer couldn't. That shortage-driven compounding is where most people's exposure to the term “compounded semaglutide” comes from, and it is still advertised by some telehealth platforms and pharmacy websites.

The regulatory picture has shifted since then. This page is not a guide to acquiring compounded semaglutide — it's a comparison of what you would actually be getting relative to brand-name Ozempic or Wegovy, so you can ask an informed set of questions if the option comes up.

The One-Line Answer

The one-line answer: compounded semaglutide is a pharmacist-prepared version of the same active ingredient, made available when brand-name product was in shortage; it is not FDA-approved, and its legal availability has narrowed considerably since the FDA declared the shortage resolved — verify a pharmacy's licensing and sourcing carefully before considering it.

Medical Disclaimer

This guide provides general information and is not medical advice. Talk to your prescriber or pharmacist before starting, stopping, or changing any medication, supplement, or device used alongside GLP-1 therapy.

Compounded vs Brand-Name Semaglutide at a Glance

Category Compounded Semaglutide Brand-Name (Ozempic / Wegovy)
What it is A pharmacist-prepared preparation containing semaglutide, sometimes combined with other ingredients such as B12 An FDA-approved, manufactured drug product with a fixed, tested formulation
FDA review status Not FDA-approved; not evaluated by the FDA for safety, effectiveness or manufacturing quality FDA-approved after clinical trials and manufacturing inspection
Who can legally make it Licensed 503A pharmacies (patient-specific) or 503B outsourcing facilities, under narrower conditions since the shortage was declared resolved Novo Nordisk, under FDA-regulated manufacturing
Sourcing and purity Varies by pharmacy; the FDA has flagged quality issues, including unapproved salt forms, at specific compounders Manufactured under consistent, inspected conditions with a stable, published formulation
Cost framing Often marketed as lower-cost than brand-name list price; the real comparison is against your own insured cost, not list price List price is high without insurance; with-insurance cost varies enormously by plan and diagnosis
Who it may suit Someone considering it should independently verify the specific pharmacy's licensing, sourcing and current legal status Someone with insurance coverage, who wants an FDA-approved product, or whose prescriber doesn't consider compounding appropriate for them

What “Compounding” Actually Means

Pharmacy compounding is a long-standing, legal practice for customizing medications — adjusting a dose, removing an allergen, or combining ingredients — generally for patients whose needs an FDA-approved product doesn't meet. There are two relevant categories: 503A pharmacies compound patient-specific prescriptions on a smaller scale, while 503B outsourcing facilities compound in larger batches under manufacturing standards closer to, but not identical to, full FDA drug approval.

Why It Became Available: The 2022–2024 Shortage

Demand for semaglutide surged once its weight-loss effects became widely known, and brand-name manufacturing couldn't keep pace. Under FDA rules, a pharmacy can compound a version that is “essentially a copy” of an approved drug only while that drug is officially listed as being in shortage. The FDA declared the semaglutide shortage resolved in March 2024, which changed what compounding is legally permitted going forward.

The Current Legal and Regulatory Status

Once a shortage is resolved, 503A pharmacies generally must stop compounding an essentially-a-copy version of the now-available brand drug. 503B outsourcing facilities have narrower continued allowances under specific conditions, such as a documented clinical need for a different dose or form. This area has been legally contested and FDA guidance has continued to evolve, so confirm current status directly with any pharmacy you're considering, and independently if possible, rather than relying on marketing claims alone.

Safety and Quality Questions Worth Asking

Because compounded drugs aren't FDA-reviewed, quality depends entirely on the individual pharmacy. Worth asking before considering one: is this a 503A or 503B facility, and is it licensed in your state? Where does the active pharmaceutical ingredient come from, and will they provide a certificate of analysis? Is the formulation the same salt form as the FDA-approved drug, or a different one? The FDA has issued safety communications about adverse events tied to dosing errors and unapproved salt forms in some compounded semaglutide products, which is exactly the kind of issue these questions are meant to surface.

Cost Framing: Why the Comparison Isn't Simple

Compounded product is often marketed as cheaper than brand-name list price, but the comparison that actually matters is against your own insured cost for brand-name product, which can be dramatically lower or higher depending on your plan and diagnosis. A pure price comparison also ignores the quality-oversight difference between an FDA-approved manufacturing process and an individual pharmacy's own sourcing and practices.

Telehealth Platforms and What They Can and Can't Promise

Many telehealth platforms have marketed compounded GLP-1 medications directly to consumers, and not all of them are equally rigorous about the sourcing and licensing questions above. It's worth identifying the actual dispensing pharmacy behind any telehealth service, rather than evaluating the platform's brand and marketing alone.

Supporting Products People on Either Medication Use

None of these are the medications themselves — prescription drugs aren't something to buy off a product list. These are the everyday supplies and supports that come up regardless of which of the two medications above someone ends up on.

Injection Supplies
Alcohol Prep Pads, Bulk Pack

A recurring, easy-to-forget supply need regardless of which product a person uses, and cheap enough to keep well stocked.

View on Amazon →
Sharps Disposal
FDA-Cleared Sharps Disposal Container

Proper sharps disposal has actual legal requirements in most places; a cleared container is an inexpensive way to handle it correctly at home.

View on Amazon →
Tracking Dose and Symptoms
Medication Log and Symptom Tracker Notebook

Useful for bringing a clear record to your prescriber, especially if you're comparing how you tolerate different products over time.

View on Amazon →
General Nutrition Support
Standalone Multivitamin with B12

Some compounded formulations bundle in B12 or other additives; a separate, clearly labeled multivitamin is a more verifiable way to cover the same nutritional bases.

View on Amazon →

Questions to Bring to Your Prescriber

This page intentionally doesn't end in a verdict. Which medication is right for you depends on details a comparison page can't see — your labs, your history, your insurance plan, and how your body responds. These are the questions worth bringing to that conversation:

  • Is compounded semaglutide currently a legal option for someone in my situation, given today's shortage status?
  • If I'm considering a compounding pharmacy, is it a 503A or 503B facility, and can you help me verify its licensing?
  • Where does the active ingredient come from, and can the pharmacy provide a certificate of analysis?
  • Is the compounded product the same salt form as the FDA-approved drug, or a different one?
  • Would monitoring for side effects differ at all compared with brand-name product?
  • What would my actual out-of-pocket cost be for brand-name semaglutide with my specific insurance, before comparing it to a compounded price?
  • If something goes wrong with a compounded product, what is the reporting and recourse process?

Related GLP-1 Explained Guides

A comparison page answers which one. It doesn't cover everything else that comes up regardless of which option you're on:

Frequently Asked Questions

Is compounded semaglutide the same as Ozempic or Wegovy?

It contains the same active ingredient in most cases, but it is not the FDA-approved product — it hasn't gone through the same manufacturing review, and details like salt form, concentration and inactive ingredients can differ from pharmacy to pharmacy.

Is compounded semaglutide still legal to get?

It depends on the pharmacy type and current shortage status, which has changed since the FDA declared the semaglutide shortage resolved in March 2024. 503B outsourcing facilities have narrower continued allowances than 503A pharmacies did during the shortage itself. This area continues to evolve, so verify current rules with the pharmacy and, ideally, independently.

Has the FDA raised safety concerns about compounded semaglutide?

Yes — the FDA has issued communications about adverse events tied to dosing errors with compounded semaglutide products, including cases involving unapproved salt forms not used in the FDA-approved drug. That doesn't mean every compounded product is unsafe, but it's a reason to ask sourcing and formulation questions before use.

Is compounded semaglutide actually cheaper?

Often marketed that way relative to brand-name list price, but the comparison that matters is against your own insured cost for brand-name product, which varies enormously by plan. There's no single answer, and price alone doesn't capture the quality-oversight difference.

Should I ask my prescriber before considering a compounded option?

Yes. A prescriber can help you assess whether it's currently a legitimate option given shortage status, whether a specific pharmacy appears legitimate, and how it might affect monitoring for side effects.

A resource for your family
Scam calls targeting older adults are at record levels — the FBI logged $7.75 billion in reported losses from adults 60+ in 2025. Our free, no-signup guides show families exactly how the calls work — and the four rules that stop them.
Visit Scam-Proof Your Parents →
Weekly Research Digest
Get the free GLP-1 Protocol Log - plus the weekly digest

A 12-week fillable log: injections and site rotation, side effects, daily protein against a muscle-preservation target, and the page you bring to your prescriber.

No spam. Unsubscribe any time.
Losing weight? Don't lose muscle.
Up to 40% of GLP-1 weight loss can be muscle. The GLP-1 Protein Playbook shows you exactly how to protect it — with 25 high-protein meals that go down easy on a killed appetite.
Get the Playbook → $19